KDR and glioblastoma: Immunohistochemistry (IHC) for both proteins in a series of 79 glioblastoma tissues demonstrated that of these, 54 tumors were either positive for PTEN or tumoral VEGFR-2 expression, and 25 tumors were negative for both markers (Table 1).